These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 14729640)
1. Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275. Camphausen K; Burgan W; Cerra M; Oswald KA; Trepel JB; Lee MJ; Tofilon PJ Cancer Res; 2004 Jan; 64(1):316-21. PubMed ID: 14729640 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid. Camphausen K; Cerna D; Scott T; Sproull M; Burgan WE; Cerra MA; Fine H; Tofilon PJ Int J Cancer; 2005 Apr; 114(3):380-6. PubMed ID: 15578701 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation. Camphausen K; Scott T; Sproull M; Tofilon PJ Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6066-71. PubMed ID: 15447991 [TBL] [Abstract][Full Text] [Related]
4. The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells. Maggio SC; Rosato RR; Kramer LB; Dai Y; Rahmani M; Paik DS; Czarnik AC; Payne SG; Spiegel S; Grant S Cancer Res; 2004 Apr; 64(7):2590-600. PubMed ID: 15059916 [TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590 [TBL] [Abstract][Full Text] [Related]
6. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci. Munshi A; Tanaka T; Hobbs ML; Tucker SL; Richon VM; Meyn RE Mol Cancer Ther; 2006 Aug; 5(8):1967-74. PubMed ID: 16928817 [TBL] [Abstract][Full Text] [Related]
7. Postradiation sensitization of the histone deacetylase inhibitor valproic acid. Chinnaiyan P; Cerna D; Burgan WE; Beam K; Williams ES; Camphausen K; Tofilon PJ Clin Cancer Res; 2008 Sep; 14(17):5410-5. PubMed ID: 18765532 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models. Qian DZ; Wei YF; Wang X; Kato Y; Cheng L; Pili R Prostate; 2007 Aug; 67(11):1182-93. PubMed ID: 17520666 [TBL] [Abstract][Full Text] [Related]
10. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells. Lee BI; Park SH; Kim JW; Sausville EA; Kim HT; Nakanishi O; Trepel JB; Kim SJ Cancer Res; 2001 Feb; 61(3):931-4. PubMed ID: 11221885 [TBL] [Abstract][Full Text] [Related]
11. MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors. Jaboin J; Wild J; Hamidi H; Khanna C; Kim CJ; Robey R; Bates SE; Thiele CJ Cancer Res; 2002 Nov; 62(21):6108-15. PubMed ID: 12414635 [TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine. Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331 [TBL] [Abstract][Full Text] [Related]
13. Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of gammaH2AX foci. Camphausen K; Brady KJ; Burgan WE; Cerra MA; Russell JS; Bull EE; Tofilon PJ Mol Cancer Ther; 2004 Apr; 3(4):409-16. PubMed ID: 15078984 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo radiosensitization induced by the ribonucleotide reductase inhibitor Triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone). Barker CA; Burgan WE; Carter DJ; Cerna D; Gius D; Hollingshead MG; Camphausen K; Tofilon PJ Clin Cancer Res; 2006 May; 12(9):2912-8. PubMed ID: 16675588 [TBL] [Abstract][Full Text] [Related]
15. Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts. Baschnagel A; Russo A; Burgan WE; Carter D; Beam K; Palmieri D; Steeg PS; Tofilon P; Camphausen K Mol Cancer Ther; 2009 Jun; 8(6):1589-95. PubMed ID: 19509253 [TBL] [Abstract][Full Text] [Related]
16. [MS-275, a histone deacetylase inhibitor, induces apoptosis and alters survivin gene expression in human myeloma cell line U266]. Ma J; Zhao M; Yu XD; Wang ZH Ai Zheng; 2009 May; 28(5):466-71. PubMed ID: 19624872 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis. Chung YL; Lee MY; Pui NN Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790 [TBL] [Abstract][Full Text] [Related]
18. Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced. Kamitani H; Taniura S; Watanabe K; Sakamoto M; Watanabe T; Eling T Neuro Oncol; 2002 Apr; 4(2):95-101. PubMed ID: 11916500 [TBL] [Abstract][Full Text] [Related]
19. Involvement of insulin-like growth factor-binding protein-3 in the effects of histone deacetylase inhibitor MS-275 in hepatoma cells. Lin WH; Martin JL; Marsh DJ; Jack MM; Baxter RC J Biol Chem; 2011 Aug; 286(34):29540-7. PubMed ID: 21737444 [TBL] [Abstract][Full Text] [Related]
20. DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. Zhu WG; Lakshmanan RR; Beal MD; Otterson GA Cancer Res; 2001 Feb; 61(4):1327-33. PubMed ID: 11245429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]